Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 6.67M | $740.0M | 9.69% | -- | 2026-06-30 |
| BlackRock, Inc. | 6.16M | $683.0M | 8.95% | -80.2K | 2026-06-30 |
| Baker Bros. Advisors LP | 5.60M | $622.0M | 8.14% | -- | 2026-06-30 |
| Primecap Management Co | 3.17M | $351.0M | 4.60% | -248.7K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 3.14M | $348.0M | 4.56% | +96.2K | 2026-06-30 |
| Vanguard Capital Management LLC | 3.01M | $333.0M | 4.37% | +38.2K | 2026-06-30 |
| JPMorgan Chase & Co | 2.65M | $292.0M | 3.85% | +1.23M | 2026-06-30 |
| Perceptive Advisors LLC | 2.59M | $287.0M | 3.76% | +212.5K | 2026-06-30 |
| State Street Corp | 2.57M | $285.0M | 3.74% | +301.7K | 2026-06-30 |
| Price T Rowe Associates Inc | 2.57M | $284.0M | 3.73% | +911.3K | 2026-06-30 |
